A prominent marijuana lobbying is warning consumers against CBD-infused products claiming to guard against the coronavirus.
The National Organization for the Reform of Marijuana Laws said this week that CBD retailers have received warning letters from the U.S. Food and Drug Administration for making such unsubstantiated claims.
“If something sounds too good to be true, it likely is,” said Erik Altieri, NORML executive director.
“During these difficult times, we encourage people to be skeptical of any unsubstantiated claims, particularly those circulating online, surrounding the use of cannabis or any other uncorroborated treatment for COVID-19.”
